Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Tomislav Omrčen"'
Autor:
Tomislav Omrčen
Publikováno v:
Acta Clinica Croatica, Vol 61., Iss Supplement 3, Pp 81-85 (2022)
For many years, androgen deprivation therapy (ADT) as monotherapy has been the gold standard for metastatic hormone-sensitive prostate cancer (mHSPC) treatment. Several studies have been published within the last decade demonstrating a significant
Externí odkaz:
https://doaj.org/article/02df3b1215c240e591e6c823858869ae
Autor:
Josipa Flam, Mario Boban, Vesna Bišof, Marko Zelić, Zdravko Perko, Eduard Vrdoljak, Nadan Rustemović, Jasna Radić, Meliha Solak Mekić, Antonio Juretić, Davor Štimac, Željko Krznarić, Ante Bolanča, Tomislav Omrčen, Ingrid Belac Lovasić, Ivica Sjekavica, Stjepko Pleština, Slavko Gašparov
Publikováno v:
Liječnički vjesnik. 140:285-292
Although the incidence of the most frequent malignant gastric tumour, adenocarcinoma, has been decreasing, during the last decades the incidence of proximal localizations of gastric cancer as well as esophagogastric cancer has been increasing. Due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8754d25882d7c0c1c7a824dca7dc7da
https://doi.org/10.26800/lv-140-11-12-38
https://doi.org/10.26800/lv-140-11-12-38
Publikováno v:
Anti-cancer drugs. 31(7)
Treatment with abiraterone acetate or enzalutamide is one of the approved approaches in men with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting. However, a significant fraction of patients do not respond to trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0cecc36fd64feb4e42ac0babf7ae85d
https://pubmed.ncbi.nlm.nih.gov/32516165
https://pubmed.ncbi.nlm.nih.gov/32516165
Autor:
Tamás Dienes, Eduard Vrdoljak, Lajos Géczi, Žarko Bajić, Claude Magri, Tomislav Omrčen, Marija Gamulin, Lidija Bošković
Publikováno v:
Neoplasma. 68(1)
The objective of our study was to assess the real-world safety and efficacy of nivolumab in the second- or later-line treatment of metastatic renal cell carcinoma (mRCC). We conducted a multicenter, retrospective, observational study of real-world da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70a20366435101c9f7039b89d47bfcc0
https://pubmed.ncbi.nlm.nih.gov/32940046
https://pubmed.ncbi.nlm.nih.gov/32940046
Publikováno v:
Anti-cancer drugs. 31(5)
In 2011, we demonstrated that bevacizumab in combination with capecitabine as first-line treatment is effective in elderly patients with metastatic colorectal cancer (mCRC). We present the final results of the study with data on tumor molecular biolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e762b29eefd87d79cbc223fd8125344a
https://pubmed.ncbi.nlm.nih.gov/31922963
https://pubmed.ncbi.nlm.nih.gov/31922963
Autor:
Ilijan Tomaš, Josipa Flam, Željko Vojnović, Antonio Juretić, Davor Štimac, Eduard Vrdoljak, Leonardo Patrlj, Liana Cambj Sapunar, Robert Šeparović, Marko Zelić, Hrvoje Šobat, Stjepko Pleština, Zdravko Perko, Tomislav Omrčen, Damir Miletić, Ingrid Belac Lovasić, Slavko Gašparov, Ante Bolanča, Marijo Boban, Željko Krznarić
Publikováno v:
Liječnički vjesnik. 140:241-247
Colorectal cancer (CRC) is one of the most common malignant tumors in Western countries. The treatment outcomes of this disease have improved significantly in recent years due to the improvement of diagnostic methods (pathohistology, radiology, nucle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc3449cee13b8052a89518bcbd692fc1
https://doi.org/10.26800/lv-140-9-10-31
https://doi.org/10.26800/lv-140-9-10-31
Autor:
Zvonimir Curić, Tomislav Sorić, Igor Tomašković, Tihana Boraska Jelavić, Kristijan Krpina, Željko Kaštelan, Tomislav Kuliš, Dražen Huić, Vesna Bišof, Ana Marija Alduk, Dag Zahirović, Marija Gamulin, Mladen Solarić, Stela Bulimbašić, Katarina Vilović, Tomislav Omrčen, Ante Punda, Blanka Jakšić, Ana Fröbe
Publikováno v:
Liječnički vjesnik. 141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d013d13c66e0589ec05e76c19042d10
https://doi.org/10.26800/lv-141-11-12-41
https://doi.org/10.26800/lv-141-11-12-41
Publikováno v:
Nuclear Medicine Communications. 39:593-596
Background In radioiodine thyroid dosimetry, the serial uptake measurements are variously analyzed, but an underlying model, derived from plausible assumptions, is lacking. Methods We derived that, upon oral administration, the intrathyroid iodine ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9606bfc81ae886adf13ae9655a29e48e
https://doi.org/10.1097/mnm.0000000000000846
https://doi.org/10.1097/mnm.0000000000000846
Autor:
Ana Marija Alduk, Damir Miletić, Maja Drežnjak Madunić, Valdi Pešutić Pisac, Milena Gnjidić, Stela Bulimbašić, Marija Gamulin, Mislav Čonkaš, Marijana Jazvić, Nikola Knežević, Tomislav Sorić, Tomislav Omrčen, Marijan Šitum
Publikováno v:
Liječnički vjesnik. 141
Testicular tumors are the most common solid tumors in men between age 15- 34 years. The worldwide incidence of these tumors has doubled in the past 40 years. Germ cell tumors comprise 95% of malignant tumors arising in the testes and they are classif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75890ce1d0a29a35b7cb67325db743a3
https://doi.org/10.26800/lv-141-11-12-44
https://doi.org/10.26800/lv-141-11-12-44
Autor:
Berislav Mažuran, Božo Krušlin, Maja Drežnjak Madunić, Ana Marija Alduk, Damir Miletić, Marija Gamulin, Željko Vojnović, Marijan Šitum, Boris Ružić, Tomislav Omrčen, Kristina Situm, Marijana Jazvić, Valdi Pešutić Piasc, Marijana Ćorić, Tihana Boraska Jelavić, Jure Murgic
Publikováno v:
Liječnički vjesnik. 141
Bladder cancer is the second most common malignancy of urinary system according to data from the Croatian National Cancer Registry for 2015. In 90% of cases the underlying histology is urothelial carcinoma. Difference in survival in patients with mus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2de4a83e34909445c6504df5122eb21c
https://doi.org/10.26800/lv-141-11-12-42
https://doi.org/10.26800/lv-141-11-12-42